Seeking Alpha · 28 Oct 2026, 15:21 UTCSK hynix: Don't Panic Over The Immediate Threat Of CXMT's 4F Squared Efforts (NASDAQ:SKHY) | Seeking AlphaASML6.8% of IVSI
Seeking Alpha · 28 Oct 2026, 07:02 UTCASML: Exceptional Semiconductor Business, Expensive Valuation (NASDAQ:ASML) | Seeking AlphaASML6.8% of IVSI
Seeking Alpha · 27 Oct 2026, 19:00 UTCTech Bubble Will Pop In 2027 (undefined:ANT) | Seeking AlphaASML6.8% of IVSI
Seeking Alpha · 28 Oct 2026, 18:55 UTCRoche: Valuation Leaves Limited Upside (OTCMKTS:RHHBF) | Seeking AlphaRoche Holding3.4% of IVSI
24/7 Wall St. · 27 Oct 2026, 16:46 UTCASML's $812 Million Dividend: What Shareholders Collect on Nov. 4ASML6.8% of IVSI
The Manila times · 28 Oct 2026, 06:07 UTCRoche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesotheliomaRoche Holding3.4% of IVSI
wallstreet:online · 28 Oct 2026, 06:05 UTCDKSH Expands its Healthcare Own Brands Portfolio With the Acquisition of Rocephin From RocheRoche Holding3.4% of IVSI
newKerala.com · 27 Oct 2026, 03:30 UTCPiyush Goyal meets ASML, Nexperia, IKEA and Power2X on India tiesASML6.8% of IVSI
LatestLY · 27 Oct 2026, 03:12 UTCBusiness News | Goyal Holds Talks with Global Firms on Semiconductors, Manufacturing, Clean EnergyASML6.8% of IVSI
Asian News International (ANI) · 27 Oct 2026, 02:59 UTCGoyal holds talks with global firms on semiconductors, manufacturing, clean energyASML6.8% of IVSI
Quartz · 28 Oct 2026, 17:20 UTCLilly's retatrutide more than doubled Ozempic weight loss in trialNovo NordiskNVO2.2% of IVSI
wallstreet:online · 28 Oct 2026, 14:05 UTCSandoz reports strong biosimilar-sales momentum; narrowed full-year net-sales range and upgrade to margin guidanceNovartisNVS2.3% of IVSI
Seeking Alpha · 27 Oct 2026, 00:30 UTCTCW Concentrated Large Cap Growth Fund Q3 2026 Commentary (TGCEX) | Seeking AlphaASML6.8% of IVSI
Quartz · 28 Oct 2026, 16:16 UTCBest-selling drugs 2026: 7 of the top 10 by 2025 salesNovo NordiskNVO2.2% of IVSI
Seeking Alpha · 28 Oct 2026, 12:00 UTCSandoz Group AG (SDZNY) Q3 2026 Sales/Trading Call Transcript | Seeking AlphaNovartisNVS2.3% of IVSI
Quartz · 28 Oct 2026, 14:15 UTCNew weight-loss drugs: what 6 drugmakers are testingNovo NordiskNVO2.2% of IVSI
Seeking Alpha · 26 Oct 2026, 22:15 UTCASML: Creating Its Own Bottleneck (NASDAQ:ASML) | Seeking AlphaASML6.8% of IVSI
The Manila times · 28 Oct 2026, 11:10 UTCMonte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)NovartisNVS2.3% of IVSI
Bloomberg Business · 28 Oct 2026, 18:59 UTCDeutsche Telekom Is Said to Hit Brakes on Giant T-Mobile MergerDeutsche Telekom1.8% of IVSI